Bio path Holdings inc (BPTH) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access BPTH Annual Balance Sheets →
The table below presents a historical view of Bio path Holdings inc's balance sheet, supporting analysis of financial position trends.
Quarterly Report, GAAP in USD millions
ITEM
(Mar 31 2026)
(Dec 31 2025) (Sep 30 2025) (Jun 30 2025) (Mar 31 2025)
Assets
Cash & cash equivalent0.01
Cash & Short-term Investments0.00
Other Current Assets0.19
Prepaid Expense, Current AS0.47
Total Current Assets0.68
Equipment/Property/Plant Net0.00
Other Assets, Noncurrent0.00
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents-
Operating Lease Right Of Use Asset-
Total Assets0.68
Liabilities
Accounts Payable, Current AC5.16
Accrued Liabilities, Current AC3.02
Derivative Liability LI0.46
Notes Payable, Current NO0.51
Total Current Liabilities9.15
Total Long-term Debt0.00
Other liabilities, Noncurrent0.01
Operating Lease Liability Current-
Total Liabilities9.16
Stockholders' Equity
Common Stock Value0.01
Additional Paid In Capital Common Stock117.95
Retained Earnings / Accumulated Deficit-126.45
Defined Benefit Plan and Other0.01
Other Equity-0.01
Common Stockholder's Equity-8.49
Preferred Stockholder's Equity0.00
Total Stockholder's Equity-8.49
Liabilities & Stockholder's Equity0.68
4 historic quarters locked

Sign in to unlock the full Bio path Holdings inc balance sheet history.

About Bio Path Holdings Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001663577-26-000156

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.